Catching cancer at an early stage is key to a successful outcome and could be achieved with a simple, fast, accurate and inexpensive cancer screen. Blood tests are seen as a highly desirable solution as they are minimally invasive and researchers have worked hard to identify blood biomarkers that can help with diagnosis. The challenge with current methods is their slow speed, the coordination of results from multiple tests and the need to perform them for large numbers of patient samples. As SMi's technology can simultaneously detect, distinguish, and count different types of single molecules, it is the perfect choice for such an application.
Read More